litlas
ログインアカウント作成

Nina P. Paynter

2000–2024 年に発表

41
論文数
35,892
被引用数
35
h 指数
41
i10 指数

被引用数

Nina P. Paynter の年別被引用数1930 年: 被引用 1 件1953 年: 被引用 1 件1967 年: 被引用 1 件1973 年: 被引用 1 件1985 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 2 件1999 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 1 件2003 年: 被引用 5 件2004 年: 被引用 17 件2005 年: 被引用 29 件2006 年: 被引用 14 件2007 年: 被引用 34 件2008 年: 被引用 34 件2009 年: 被引用 49 件2010 年: 被引用 116 件2011 年: 被引用 260 件2012 年: 被引用 475 件2013 年: 被引用 661 件2014 年: 被引用 905 件2015 年: 被引用 741 件2016 年: 被引用 527 件2017 年: 被引用 363 件2018 年: 被引用 276 件2019 年: 被引用 915 件2020 年: 被引用 897 件2021 年: 被引用 694 件2022 年: 被引用 522 件2023 年: 被引用 416 件2024 年: 被引用 533 件2025 年: 被引用 240 件2026 年: 被引用 23 件1931〜1952 年は被引用が無いため表示していません1954〜1966 年は被引用が無いため表示していません1968〜1972 年は被引用が無いため表示していません1974〜1984 年は被引用が無いため表示していません1986〜1994 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,435 件、この内訳の 33.3%中国: 引用元論文 1,038 件、この内訳の 7.8%イギリス: 引用元論文 795 件、この内訳の 6%カナダ: 引用元論文 605 件、この内訳の 4.5%ドイツ: 引用元論文 531 件、この内訳の 4%イタリア: 引用元論文 521 件、この内訳の 3.9%オランダ: 引用元論文 382 件、この内訳の 2.9%オーストラリア: 引用元論文 378 件、この内訳の 2.8%スペイン: 引用元論文 329 件、この内訳の 2.5%フランス: 引用元論文 294 件、この内訳の 2.2%日本: 引用元論文 270 件、この内訳の 2%スウェーデン: 引用元論文 251 件、この内訳の 1.9%
0%33.3%その他 26.2%

機関

分野

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Immunology and Microbiology3.9%
  • Neuroscience3.7%
  • Engineering2.5%
  • Health Professions2.1%
  • その他8%

トピック

  • Lipoproteins and Cardiovascular Health2.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.5%
  • Stroke Rehabilitation and Recovery2%
  • Cardiovascular Function and Risk Factors1.9%
  • Heart Failure Treatment and Management1.9%
  • Atherosclerosis and Cardiovascular Diseases1.9%
  • その他87%

共著者

全論文

検索で開く
  1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

    著者: Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart, Jean MacFadyen, Elaine Zaharris, Brendan M. Everett, Stuart Campbell, Ryu Oshima, Pierre Amarenco, Dirk Blom, Eliot A. Brinton, Robert H. Eckel, Marshall B. Elam, João Soares Felício, Henry N. Ginsberg, Assen Goudev, Shun Ishibashi, Jacob Joseph, Tatsuhiko Kodama, Wolfgang Köenig, Lawrence A. Leiter, Alberto Lorenzatti, Boris Mankovsky, Nikolaus Marx, Børge G. Nordestgaard, Dénes Páll, Kausik K. Ray, Raúl D. Santos, Handrean Soran, Andrey V. Susekov, Michał Tendera, Koutaro Yokote, Nina P. Paynter, Julie E. Buring, Peter Libby, Paul M. Ridker - New England Journal of Medicine 2022 被引用: 711

  2. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

    著者: Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan, Jean MacFadyen, Daniel H. Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga, Milan Gupta, Michelle Tsigoulis, Subodh Verma, Michael Clearfield, Peter Libby, Samuel Z. Goldhaber, Roger L. Seagle, Cyril Ofori, Mohammad G. Saklayen, Samuel Butman, Narendra Singh, Michel Le May, Olivier F. Bertrand, James Johnston, Nina P. Paynter, Robert J. Glynn - New England Journal of Medicine 2018 被引用: 1,294

  3. Heart Disease and Stroke Statistics—2012 Update

    著者: Writing Group Members, Véronique L. Roger, Alan S. Go, Donald M. Lloyd‐Jones, Emelia J. Benjamin, Jarett D. Berry, William B. Borden, Dawn M. Bravata, Shifan Dai, Earl S. Ford, Caroline S. Fox, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Diane M. Makuc, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Elsayed Z. Soliman, Paul D. Sorlie, Nona Sotoodehnia, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo, Melanie B. Turner - Circulation 2011 被引用: 7,234

  4. Heart Disease and Stroke Statistics—2011 Update

    著者: Véronique L. Roger, Alan S. Go, Donald M. Lloyd‐Jones, Robert J. Adams, Jarett D. Berry, Todd M. Brown, Mercedes R. Carnethon, Shifan Dai, Giovanni de Simone, Earl S. Ford, Caroline S. Fox, Heather J. Fullerton, Cathleen Gillespie, Kurt J. Greenlund, Susan M. Hailpern, John A. Heit, P. Michael Ho, Virginia J. Howard, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Diane M. Makuc, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Mary Mcdermott, James B. Meigs, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Wayne D. Rosamond, Paul D. Sorlie, Randall S. Stafford, Tanya N. Turan, Melanie B. Turner, Nathan D. Wong, Judith Wylie‐Rosett - Circulation 2010 被引用: 6,168

  5. Heart Disease and Stroke Statistics—2014 Update

    著者: Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, Emelia J. Benjamin, Jarett D. Berry, Michael J. Blaha, Shifan Dai, Earl S. Ford, Caroline S. Fox, Sheila Franco, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Mark D. Huffman, Suzanne E. Judd, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Rachel H. Mackey, David J. Magid, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Michael E. Mussolino, Robert W. Neumar, Graham Nichol, Dilip K. Pandey, Nina P. Paynter, Matthew J. Reeves, Paul D. Sorlie, Joel Stein, Amytis Towfighi, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo, Melanie B. Turner - Circulation 2013 被引用: 5,230

  6. Heart Disease and Stroke Statistics—2013 Update

    著者: Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, Emelia J. Benjamin, Jarett D. Berry, William B. Borden, Dawn M. Bravata, Shifan Dai, Earl S. Ford, Caroline S. Fox, Sheila Franco, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Mark D. Huffman, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, David J. Magid, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Pamela J. Schreiner, Paul D. Sorlie, Joel Stein, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo, Melanie B. Turner - Circulation 2012 被引用: 5,186

  7. Executive Summary: Heart Disease and Stroke Statistics—2014 Update

    著者: Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, Emelia J. Benjamin, Jarett D. Berry, Michael J. Blaha, Shifan Dai, Earl S. Ford, Caroline S. Fox, Sheila Franco, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Mark D. Huffman, Suzanne E. Judd, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Rachel H. Mackey, David J. Magid, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Michael E. Mussolino, Robert W. Neumar, Graham Nichol, Dilip K. Pandey, Nina P. Paynter, Matthew J. Reeves, Paul D. Sorlie, Joel Stein, Amytis Towfighi, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo, Melanie B. Turner - Circulation 2014 被引用: 1,405

  8. Adverse Effects of Low-Dose Methotrexate

    著者: Daniel H. Solomon, Robert J. Glynn, Elizabeth W. Karlson, Fengxin Lu, Cassandra Corrigan, Josh Colls, Chang Xu, Jean MacFadyen, Medha Barbhaiya, Nancy Berliner, Paul F. Dellaripa, Brendan M. Everett, Aruna D. Pradhan, Sarah P. Hammond, Meredith Murray, Deepak A. Rao, Susan Y. Ritter, Anna Rutherford, Jeffrey A. Sparks, Jackie Stratton, Dong Hyun Suh, Sara K. Tedeschi, Kathleen M.M. Vanni, Nina P. Paynter, Paul M. Ridker - Annals of Internal Medicine 2020 被引用: 222

  9. Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice

    著者: Gijs F.N. Berkelmans, Stephanie H. Read, Soffia Gudbjörnsdottir, Sarah H. Wild, Stefan Franzen, Yolanda van der Graaf, Björn Eliasson, Frank L.J. Visseren, Nina P. Paynter, Jannick A.N. Dorresteijn - Journal of Clinical Epidemiology 2022 被引用: 100

  10. openalex_id:w4206938692

    著者: Gijs F. N. Berkelmans, Stephanie H. Read, Soffia Guðbjörnsdóttir, Sarah H. Wild, Stefan Franzén, Yolanda van der Graaf, Björn Eliasson, Frank L.J. Visseren, Nina P. Paynter, Jannick A N Dorresteijn - 2022 被引用: 65

  11. Metabolic Predictors of Incident Coronary Heart Disease in Women

    著者: Nina P. Paynter, Raji Balasubramanian, Franco Giulianini, Dong D. Wang, Lesley F. Tinker, Shuba Gopal, Amy Deik, Kevin Bullock, Kerry A. Pierce, Justin Scott, Miguel Ángel Martínez‐González, Ramón Estruch, JoAnn E. Manson, Nancy R. Cook, Christine M. Albert, Clary B. Clish, Kathryn M. Rexrode - Circulation 2018 被引用: 260

  12. Executive Summary: Heart Disease and Stroke Statistics—2013 Update

    著者: Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, Emelia J. Benjamin, Jarett D. Berry, William B. Borden, Dawn M. Bravata, Shifan Dai, Earl S. Ford, Caroline S. Fox, Sheila Franco, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Mark D. Huffman, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, David J. Magid, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Pamela J. Schreiner, Paul D. Sorlie, Joel Stein, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo, Melanie B. Turner - Circulation 2013 被引用: 1,297

  13. Tests of calibration and goodness‐of‐fit in the survival setting

    著者: Olga Demler, Nina P. Paynter, Nancy R. Cook - Statistics in Medicine 2015 被引用: 303

  14. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

    著者: Paul M. Ridker, Nina P. Paynter, Nader Rifai, J. Michael Gaziano, Nancy R. Cook - Circulation 2008 被引用: 855

  15. Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study

    著者: Caroline S. Fox, Michael J. Pencina, Peter W.F. Wilson, Nina P. Paynter, Ramachandran S. Vasan, Ralph B. D’Agostino - Diabetes Care 2008 被引用: 243

  16. Primary Prevention With Statin Therapy in the Elderly

    著者: Paul M. Ridker, Eva Lonn, Nina P. Paynter, Robert J. Glynn, Salim Yusuf - Circulation 2017 被引用: 137

  17. Executive Summary: Heart Disease and Stroke Statistics—2012 Update

    著者: Writing Group Members, Véronique L. Roger, Alan S. Go, Donald M. Lloyd‐Jones, Emelia J. Benjamin, Jarett D. Berry, William B. Borden, Dawn M. Bravata, Shifan Dai, Earl S. Ford, Caroline S. Fox, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Diane M. Makuc, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Elsayed Z. Soliman, Paul D. Sorlie, Nona Sotoodehnia, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo, Melanie B. Turner - Circulation 2012 被引用: 1,514

  18. Metabolomic profiles associated with all-cause mortality in the Women’s Health Initiative

    著者: Raji Balasubramanian, Nina P. Paynter, Franco Giulianini, JoAnn E. Manson, Yibai Zhao, Jiu‐Chiuan Chen, Mara Z. Vitolins, Christine A Albert, Clary B. Clish, Kathryn M. Rexrode - International Journal of Epidemiology 2019 被引用: 48

  19. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

    著者: Aruna D. Pradhan, Nina P. Paynter, Brendan M. Everett, Robert J. Glynn, Pierre Amarenco, Marshall B. Elam, Henry N. Ginsberg, William R. Hiatt, Shun Ishibashi, Wolfgang Köenig, Børge G. Nordestgaard, Jean‐Charles Fruchart, Peter Libby, Paul M. Ridker - American Heart Journal 2018 被引用: 321

  20. Estimating treatment effects for individual patients based on the results of randomised clinical trials

    著者: Jannick A N Dorresteijn, Frank L.J. Visseren, Paul M. Ridker, Annemarie M.J. Wassink, Nina P. Paynter, Ewout W. Steyerberg, Yolanda van der Graaf, Nancy R. Cook - BMJ 2011 被引用: 178

  21. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative

    著者: Samia Mora, Nanette K. Wenger, Nancy R. Cook, Jingmin Liu, Barbara V. Howard, Marian C. Limacher, Simin Liu, Karen L. Margolis, Lisa W. Martin, Nina P. Paynter, Paul M. Ridker, Jennifer G. Robinson, Jacques E. Rossouw, Monika M. Safford, JoAnn E. Manson - JAMA Internal Medicine 2018 被引用: 82

  22. The effect of weight loss on C-reactive protein: a systematic review.

    著者: Elizabeth Selvin, Nina P. Paynter, Thomas P. Erlinger - 2007 被引用: 323

  23. Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts

    著者: Jie Hu, Jie Yao, Shuliang Deng, Raji Balasubramanian, Monik C. Jiménez, Jun Li, Xiuqing Guo, Daniel E. Cruz, Yan Gao, Tianyi Huang, Oana A. Zeleznik, Debby Ngo, Simin Liu, Milagros C. Rosal, Rami Nassir, Nina P. Paynter, Christine M. Albert, Russell P. Tracy, Peter Durda, Yongmei Liu, Kent D. Taylor, W. Craig Johnson, Qi Sun, Eric B. Rimm, A. Heather Eliassen, Stephen S. Rich, Jerome I. Rotter, Robert E. Gerszten, Clary B. Clish, Kathryn M. Rexrode - Circulation Research 2022 被引用: 32

  24. Tailoring Risk Prediction Models to Local Populations

    著者: Aniket N. Zinzuwadia, Olga Mineeva, Chunying Li, Zareen Farukhi, Franco Giulianini, Brian E. Cade, Lin Chen, Elizabeth W. Karlson, Nina P. Paynter, Samia Mora, Olga Demler - JAMA Cardiology 2024 被引用: 25